Safety of subcutaneous specific immunotherapy with pollen allergen extracts for respiratory allergy

International Archives of Allergy and Immunology

Volumn 132, Issue 3, 2003, Pages 258-262

  Arifhodzic, N ^a   Behbehani, N ^a   Duwaisan, A R ^a   Al Mosawi, M ^a   Khan, M ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Allergic rhinitis; Asthma; Immunotherapy; Kuwait, pollen seasons; Seasonal allergic rhinitis; Subcutaneous specific immunotherapy, safety

Indexed keywords

POLLEN ANTIGEN;

ADULT; ALLERGIC REACTION; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHENOPODIUM ALBUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; EVALUATION; FEMALE; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRICK TEST; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT ALLERGY; SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; POLLEN; PROSPECTIVE STUDIES; RHINITIS, ALLERGIC, SEASONAL;

EID: 0344197644     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074307     Document Type: Article

References (21)

1. Bousquet J, Michel FB: Safety consideration in assessing the role of immunotherapy in allergic disorders. Drug Saf 1994;10:5-7.
2. Durham SR, Walker SM, Varga EM, Jacobson MJ et al: Long-term clinical efficacy of grass pollen immunotherapy. N Engl J Med 1999; 341:468-475.
3. Abramson M, Puy R, Weiner J: Immunotherapy in asthma: An updated systemic review. Allergy 1999;54:1022-1041.
4. Palma-Carlos AG, Spinola-Santos A, Ferreira MB, Santos MC, Palma Carlos ML: Immuno-therapy in allergic rhinitis. Allerg Immunol (Paris) 2001;33:323-326.
5. Jacobsen L, Nuchel Peterson B, Wihl JA, Lowenstein H, Ipsen H: Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6 years) follow-up. Allergy 1997;52:914-920.
6. Haselden BM, Kay AB, Larche M: Peptidemediated immune responses in specific immunotherapy. Int Arch Allergy Immunol 2000; 122:229-237.
7. Mellerup MT, Hahn GW, Poulsen LK, Malling H: Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extracts, disease and systemic side effects during induction treatment. Allergy 2000;55:827-835.
8. Bousquet J, Lockey RF, Malling HJ: WHO Position Paper. Allergen Immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 1998;53(suppl).
9. Behbehani N, Arifhodzic N, Al-Mousawi M, Marafie S, Ashkanani L, Moussa M, Al-Duwaisan A: The correlation between outdoor pollens and the seasonal variation in allergic rhinitis and asthma in Kuwait (abstract). Proc 6th Annual Kuwait Health Sciences Centre, Poster day, Kuwait, 2001, p 72.
10. Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institute of Health. National Heart, Lung, and Blood Institute Publication No. 95-3659, January 1995.
11. Behbehni N, Abal A, Syabbalo NC, Azeem AA, Shareef E, Al Momone J: Prevalence of asthma allergic rhinitis and eczema in 13- to 14-year-old children in Kuwait: An ISAAC study. Ann Allergy Asthma Immunol 2000;85:58-63.
12. Arifhodzic N, Al-Dowaisan AR: High prevalence of allergic sensitization to pollen allergens among schoolchildren in Kuwait. Allergy 1998(suppl):511.
13. Ezeamuzie CI, Thomson MS, Al Ali S, Al-Dowaisan AR, Khan M, Hijazi Z: Asthma in desert: Spectrum of the sensitizing aeroallergens. Allergy 2000;55:157-162.
14. Dowaisan AR, Arifhodzic N, Pradalier A: Entre allergique autre part (Allergy in the World). Ed Strategic & Numeric LCLA0006D, 2000, pp 57-69.
15. Ariano R, Kroon AM, Augeri G, Canonica GW, Passalacqua G: Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized controlled trial. Allergy 1999;54:313-319.
16. Lin MS, Tanner E, Lynn J, Friday GA Jr: Non-fatal systemic reactions induced by skin testing and immunotherapy. Ann Allergy 1993;71: 557-562.
17. Businco L, Zannino L, Cantani A, Corrias A, Fiocchi A, La Rosa M: Systemic reactions to specific immunotherapy in children with respiratory allergy: A prospective study. Pediatr Allergy Immunol 1995;6:44-47.
18. Matloff SM, Bailt IW, Parks P, Madden N, Greineder DK: Systemic reaction to immunotherapy. Allergy Proc 1993;14:347-350.
19. Winter L, Malling HJ, Mosbech H: Allergen-specific immunotherapy in birch and grass pollen allergic rhinitis. II. Side effects. Allergy 2000;55:827-835.
20. Lockey RF, Nicoara-Kasti GL, Thedoropoulus DS, Bukantz SC: Systemic reactions and fatalities associated with allergen immunotherapy. Ann Allergy Asthma Immunol 2001;87(suppl 1):47-55.
21. Tankersley MS, Butler KK, Butler WK, Goetz DW: Local reactions during allergen immunotherapy do not require dose adjustment. J Allergy Clin Immunol 2000;106:840-843.